Dr. Joshua M. Sharfstein, Principal Deputy Commissioner of Food and Drug Administration (FDA) today reaffirmed his agency’s commitment to protect the American people from unsafe or dangerous drugs. In a report to the House Subcommittee on Health Committee on Energy and Commerce, Dr Sharfstein announced that the FDA was seeking better controls to combat the threat of contamination and counterfeit drugs manufactured developing world. Dr Sharfstein announced to the House that the FDA was working close with foreign governments to ensure adherence to international standards and that the FDA had extend its number of field offices in China, India, Mexico, Costa Rica and Chile. It is estimated that up to 40 percent of drugs are imported and that 80 percent contain active ingredients made overseas. Between 2007-2008 149 people died in the United States as a result of a contaminated supply of the blood thinner Heparin, manufactured in China.
Colorado Free Case Evaluation
Please fill out the case evaluation form below, or call Burg Simpson directly at 303-792-5595 today.
Subscribe today and get the latest Burg Simpson related updates via email: